Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
about
Caffeic acid phenethyl ester up-regulates antioxidant levels in hepatic stellate cell line T6 via an Nrf2-mediated mitogen activated protein kinases pathway.Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.Nanoparticles for the treatment of liver fibrosis.How successful has targeted RNA interference for hepatic fibrosis been?Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.
P2860
Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
@nl
Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
@ast
Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
@en
type
label
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
@nl
Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
@ast
Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
@en
prefLabel
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
@nl
Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
@ast
Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
@en
P2860
P356
P1476
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
@en
P2093
Beata Nagórniewicz
P2860
P304
P356
10.1155/2016/7629724
P407
P5008
P577
2016-11-24T00:00:00Z